<p><strong>Background:</strong> Hypertension is a clinical term to describe the pressure of high blood which cause fetal morbidity due to reduced blood flow to the placenta, such as stunted fetal growth, fetal death in utero to premature birth to cause maternal morbidity such as pulmonary edema, bleeding in the brain, eclamptic seizures, blood clots in the veins, acute kidney failure and even death in the mother. Hypertension in Pregnancy is a major complication that causes 60% to 80% of maternal deaths and maternal morbidity in the worldwide. The purpose of this scoping review is to determine the factors that influence the incidence of hypertension in pregnancy.</p><p><strong>Method</strong>: Scoping Review uses the following databases: Pubmed, Wiley Online Library, and ProQuest. Search results that meet the criteria will then be parsed into articles. Study Use of the Joana Briggs Institute/JBI and synthetic methods using transforming PEOS.</p><p><strong>Results:</strong> From the 108 articles related to the title and abstract, 9 articles met the inclusion and exclusion criteria. Five factors were found, namely heredity, age, parity, gemeli and Body Mass Index/ BMI that affected Hypertension in Pregnancy<strong>. </strong></p><p><strong>Conclusion:</strong> Hypertension in pregnancy was 5-15% and it was a significant complication in pregnancy. Due to the etiology was still not clearly detected and the referral system was not definitely still perfect. It also indicated that five factors could affect the occurrence of hypertension in pregnancy which are, heredity, age, multiple pregnancies, parity, and body mass index.</p>
Newborns are at risk of losing body heat after birth. According to UNICEF, the global infant mortality rate is still worrying, in Sub-Saharan Africa, of 29 deaths per 1,000 births. It means that 80% of deaths are caused by asphyxia, complications at birth, hypothermia, and sepsis. In Indonesia, the causes of death for newborns 0-6 days include respiratory disorders (36.9%), prematurity (32.4%), sepsis (12%), hypothermia (6.8%,) and jaundice (6.6%). Evidence suggests some technological interventions in preventing hypothermia in newborns, such as skin-to-skin contact between mother and baby. This study aimed to explore available technological evidence regarding the effectiveness of IMD in the prevention of hypothermia in newborns. The review is based on the integrative review method by following the modified design it consists of identifying topics, identifying problems/questions, collecting data with relevant evidence, evaluating data, analyzing, and interpreting data, concluding, and presenting results. PRISMA flow diagram is used to show the flow of evidence search. The results of the review included 10 articles. From the review, three facts were discovered, namely, EIB can increase temperature, increase breastfeeding levels, and increase low weight loss in the baby's first days. Infant mortality can be prevented with the role of trained health workers during ANC, delivery/postnatal, and EIB during the first/two hours of postpartum to prevent hypothermia.
<p>Swampland is a prospective marginal land to be developed for rice cultivation. Rice plants that are adaptive to swampland usually have good tolerance to Fe. Previously, we obtained several rice lines tolerant to Fe toxicity in the field. This study aimed to analyze the swampy rice genotypes using STS molecular markers linked to bacterial leaf blight (BLB)-resistant genes and evaluate the resistance level of the genotypes against three BLB races under the greenhouse condition. This research was conducted in the Molecular Biology Laboratory and Greenhouse of the Indonesian Center for Agricultural Biotechnology and<br />Genetic Resources Research and Development from January to May 2021. Eighteen swampy rice varieties/lines and two check varieties for Fe toxicity and BLB, respectively, were used in this research. The eight STS molecular markers linked to BLB resistance genes were used for genotyping analysis. The results showed that all rice plants tested contained xa5 allele gene, 19 genotypes had Xa4 allele gene, 17 genotypes had Xa7 allele gene, 9 genotypes had xa13 allele gene, 5 genotypes had xa13 allele gene, and 6 genotypes had Xa4 and Xa21 allele genes. Line B146E-4 was estimated to have 7 resistance alleles genes, meanwhile lines B14301E-KA-17-a, B14315E-KA-1, and B13-1-a have 6 resistance allele genes. The resistance evaluation of the genotypes against the three BLB races (races III, IV, and VIII) under the greenhouse condition showed that line B14315E-KA-1 was confirmed to be highly resistant to BLB disease. This line can be a promising candidate for swampy rice that is resistant to<br />BLB disease.</p>
Preeclampsia is a pregnancy complication characterized by high blood pressure and proteinuria that arises after a gestational age of 20 weeks. Pre-eclampsia is one of the obstetric diseases with the most severe complication rates. Research on increasing knowledge, causes, prevention, treatment of pre-eclampsia, and strong evidence of the traumatic impact on short-term and long-term psychological health has been widely undertaken. However, there has been relatively little study on mothers' experiences with preeclampsia. This Scoping Review aims to find out the experiences of mothers with pre-eclampsia. The method used is Scoping Review using Willey Online Library, PubMed, and ScienceDirect databases. The search results that match the criteria are then analyzed to generate these articles. The appraisal study uses Joana Briggs Institute (JBI), and the synthesis method uses PEOS modification. Of the 152 articles relevant to titles and abstracts, seven articles met the inclusion and exclusion criteria. The review discovered four themes that affect mother experience with preeclampsia: maternal reaction, obstacles, impact, and coping. This study contributes to the understanding that the condition of women with preeclampsia during pregnancy and childbirth still requires medical professionals' attention, particularly regarding awareness of perceived symptoms and information regarding pregnancy with preeclampsia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.